Product Information
LUBIPROSTONE 8 MCG CAPSULE is a generic product labeled by Natco Pharma USA LLC, priced at $0.6039 per EA under NDC 69339016217. Its NADAC has been published 189 times since Nov 16, 2022.
Strength
8 ug/1
Manufacturer
Natco Pharma USA LLCNDC
69339016217
Classification
Generic
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LUBIPROSTONEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021908On Market Since
10/17/2022
Pharmacological Classes
Price Statistics
The NADAC for LUBIPROSTONE 8 MCG CAPSULE has been published 189 times since Nov 16, 2022, and over the history we have for it it has declined 86.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6039 per EA |
|---|---|
| All-time high | $4.4984 (Dec 14, 2022) |
| All-time low | $0.5447 (Nov 20, 2024) |
| 52-week high | $0.8921 |
| 52-week low | $0.6039 |
| Median price | $0.8454 |
| Average price | $1.3673 |
| Largest weekly change | -46.8% (Dec 20, 2023) |
| Weeks tracked | 189 |
| Tracking since | Nov 16, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the LUBIPROSTONE market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LUBIPROSTONE 8 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LUBIPROSTONE 8 MCG CAPSULE, manufactured by Natco Pharma USA LLC, is $0.6039 per EA (NDC 69339016217), effective Jun 24, 2026.
How has the price of LUBIPROSTONE 8 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for LUBIPROSTONE 8 MCG CAPSULE has declined 86.2%. It has been tracked across 189 weekly CMS publications since Nov 16, 2022.
What are the highest and lowest recorded NADAC prices for LUBIPROSTONE 8 MCG CAPSULE?
Since Nov 16, 2022, the NADAC for LUBIPROSTONE 8 MCG CAPSULE has ranged from a low of $0.5447 (Nov 20, 2024) to a high of $4.4984 (Dec 14, 2022), with a median of $0.8454 per EA.
Are there cheaper alternatives to LUBIPROSTONE 8 MCG CAPSULE?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LUBIPROSTONE 8 MCG CAPSULE, so no direct lower-cost alternative is listed.
Who manufactures LUBIPROSTONE 8 MCG CAPSULE?
LUBIPROSTONE 8 MCG CAPSULE (NDC 69339016217) is labeled by Natco Pharma USA LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification